Revenue and PAT rise in September 2026 quarter

Results View source PDF Explain this filing

INDRAMEDCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.3%Reaction day

₹318.60

prior close

₹312.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Hospital peers, median of 25sector+0.0%-4.3% vs sector

On the reaction day the stock moved 4.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-0.5

15m

-0.4

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.3pendingpending+0.0-4.3

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Revenue from operations rose 8.4% year on year to Rs 412.85 crore in the September 2026 quarter, while PAT increased 8.3% to Rs 53.58 crore. For the first half, revenue reached Rs 819.00 crore and PAT Rs 109.43 crore, up 9.8% and 8.4%, respectively. Operating cash flow was positive at Rs 109.35 crore, and the auditor's limited review raised no material concerns.

Likely market impact

Higher earnings and positive operating cash flow support shareholder sentiment, though year-on-year growth was modest.